A new contender in the fight against lung cancer has emerged,…
Category: Oncology
Home /
Tecelra®, the first engineered T-cell therapy for solid tumors, has received…
Clinical trial results show that pembrolizumab, an immunotherapy drug used to…
In the early days of the human immunodeficiency virus (HIV) epidemic,…
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed…
Around 200,000 people die from glioblastoma, the most common and most…
Recent revelations by celebrities about their cancer diagnoses have cast a…
In 2024, roughly 2 million people in the United States will…
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing…
The future of oncology holds immense promise, thanks to the tireless…
Death rates for cancer are lower than ever, having declined as…
The relationship between cancer and the nervous system has been a…
Humans have practiced oncology — the study and treatment of cancer…
Infographics A recent scientific survey conducted by DermTech, Inc. identified a…
Recent years have seen increased research interest in the potential of…
Colonoscopies have historically been the dominant method of screening for early…
Recent advancements have led to the development of new cancer therapies…
There are ten times more bacterial cells in your body than…
Like bacteria, fungal microorganisms are an important part of the human…
A potential new cancer drug delivery method — through the gut’s…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
Webinars
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso and
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma in
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal cancer
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making people
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with primary
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival rate
Understanding the Rise in Cancer Rates Among Young Adults
May 13, 2024
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the incidence
Oncology Clinical Trials: Understanding Industry Challenges
May 8, 2024
In 2024, roughly 2 million people in the United States will be diagnosed with cancer, per the National Cancer Institute. Given that stark statistic, oncology
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine learning
The Future of Oncology Treatment
May 1, 2024
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements in
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in oncology
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the early
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology drug
Skin Cancer Risk Concerningly High in Millennials & Gen Xers
May 24, 2023
Infographics A recent scientific survey conducted by DermTech, Inc. identified a number of alarming trends concerning the sun exposure habits and skin health knowledge of
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify T
Is Stool Screening an Effective Tool for Preventing Colon Cancer?
February 15, 2023
Colonoscopies have historically been the dominant method of screening for early detection of colon cancer, the third leading cause of cancer death in the United
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021, the
Cancer Trials Ask, What’s the Gut Got to Do With It?
November 7, 2022
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in between.
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
October 31, 2022
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past two
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce side
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
